Syngene International Ltd

NSE :SYNGENE   BSE :539268  Sector : Healthcare
Buy, Sell or Hold SYNGENE? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

13 Nov
862.75
(-2.99%)
12 Nov
889.30
(0.06%)
11 Nov
888.75
(-1.08%)
08 Nov
898.45
(-1.65%)
07 Nov
913.50
(1.07%)
06 Nov
903.85
(4.16%)
05 Nov
867.75
(0.29%)
04 Nov
865.20
(0.45%)
01 Nov
861.35
(0.13%)
31 Oct
860.25
(-0.19%)
30 Oct
861.85
(1.48%)
29 Oct
849.25
(-2.53%)
28 Oct
871.30
(-0.41%)
25 Oct
874.85
(-0.56%)
24 Oct
879.75
(5.13%)
23 Oct
836.85
(-0.22%)
22 Oct
838.70
(-1.92%)
21 Oct
855.15
(-2.54%)
18 Oct
877.40
(-0.13%)
17 Oct
878.55
(-0.86%)
16 Oct
886.15
(-0.08%)


Technical Analysis

Short Term Investors

Neutral

Medium Term Investors

Very Bearish

Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

889.7


10 DMA
Bearish

881


20 DMA
Bearish

871.58


50 DMA
Bearish

885.75


100 DMA
Bullish

836.07


200 DMA
Bullish

770.61



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 13, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 924.41 907.78 873.52 - -
R2 907.78 892.82 869.93 906.31 -
R1 885.26 883.59 866.34 882.32 896.53
P 868.63 868.63 868.63 867.16 874.26
S1 846.11 853.67 859.16 843.17 857.38
S2 829.48 844.44 855.57 828.01 -
S3 806.96 829.48 851.98 - -

Key Metrics

EPS

10.91

P/E

78.77

P/B

8.01

Dividend Yield

0.15%

Market Cap

34,729 Cr.

Face Value

10

Book Value

107.28

ROE

12.95%

EBITDA Growth

260.3 Cr.

Debt/Equity

0.17

Shareholding Pattern

  54.72% Total Promoter Holding
13.58% Mutual Fund Holdings
20.72% FIIs
6.74% Non Institution
2.91% Insurance Companies
0.34% Custodians
0.99% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Syngene International Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 931.7 882.8 933 839.8 907.5
PROFIT 122.22 114.49 188.6 51.79 106.1
EPS 2.9 2.78 4.7 1.89 2.64

Syngene International Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 851.7 820.7 880 776.2 837.7
PROFIT 107.35 102.76 189.8 49.96 96.6
EPS 2.53 2.49 4.73 1.84 2.41

Profit & Loss (Figures in Rs. Crores)


Syngene International Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1498.4 1874.7 2164 2309.1 2678.6 3305.8 3522.6
PROFIT 289.35 328.12 358.49 379.76 417.63 470.41 520.91
EPS 7.64 8.29 10.3 10.12 9.88 11.57 12.69

Syngene International Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 881.9 1117.7 1293.9 1498.4 1874.7 2164 2304.2 2730.6 3306.4 3234.5
PROFIT 175 240.8 286.74 289.05 327.22 357.85 378.54 415.64 470.5 466.99
EPS 7.82 5.92 7.19 7.63 8.27 10.29 10.09 9.83 11.78 11.6

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 402401.4400.8400400200200
Reserves Total 3,855.83,216.62,896.82,421.41,775.81,768.41,520.4
Total Shareholders Funds4,257.83,6183,297.62,821.42,175.81,968.41,720.4
Secured Loans 141.7575.3531.5512.4376.7606.6692.6
Unsecured Loans 413.5239.9490.1380.5396.2206.794.8
Total Debt555.2815.21,021.6892.9772.9813.3787.4
Other Liabilities284.5321.6295.6311.2366.7244.899.5
Total Liabilities5,097.54,754.84,614.84,025.53,315.43,026.52,607.3
APPLICATION OF FUNDS :
Gross Block 5,011.64,546.93,943.53,4603,017.22,1711,660.7
Less: Accumulated Depreciation2,161.61,8801,550.71,259997.5794.2630.3
Net Block2,8502,666.92,392.82,2012,019.71,376.81,030.4
Capital Work in Progress838.1176.9346.4237.2234.1273.7155.4
Investments 547.9918.51,034.1702776.4716157.7
Inventories 238.5332.8179.459.625.243.486
Sundry Debtors 441.6529.3507.7475.7398.2338.7266.8
Cash and Bank Balance563.5531.7517.9642.6281.5436.9967.4
Loans and Advances 202.2207.1237.1205.5169.3229.1242.3
Total Current Assets1,445.81,600.91,442.11,383.4874.21,048.11,562.5
Current Liabilities 933.81,010.5866.8797.8794.3640.2555.4
Provisions 120.365.782.259.953.236.826.3
Total Current Liabilities & Provisions1,054.11,076.2949857.7847.5677581.7
Net Current Assets391.7524.7493.1525.726.7371.1980.8
Deferred Tax Assets182.6194.1190.7188.9208.3124.6118.4
Deferred Tax Liability141.9124.5125.199.885.633.146
Net Deferred Tax40.769.665.689.1122.791.572.4
Other Assets429.1398.2282.8270.5135.8197.4210.6
Total Assets5,097.54,754.84,614.84,025.53,315.43,026.52,607.3
Contingent Liabilities1,269.21,243.81,095.6859.6424.7335.9476.8
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 402401.4400.8400400200200200200199.1
Reserves Total 3,789.53,217.52,891.22,418.31,774.11,767.21,520.11,224.4824.7645.8
Equity Application Money0000000-11.300
Total Shareholders Funds4,191.53,618.93,2922,818.32,174.11,967.21,720.11,413.11,024.7844.9
Secured Loans 141.7575.3531.5512.4376.7606.6692.6689.889118.6
Unsecured Loans 190.763.3490.1380.5396.2206.794.8116.60136.4
Total Debt332.4638.61,021.6892.9772.9813.3787.4806.4891155
Other Liabilities281.9319.6295.6311.2366.7244.899.571.671.677.9
Total Liabilities4,805.84,577.14,609.24,022.43,313.73,025.32,6072,291.11,987.31,077.8
APPLICATION OF FUNDS :
Gross Block 4,3714,070.73,943.53,4603,017.22,1711,660.71,331.91,111.4938
Less : Accumulated Depreciation 2,053.11,810.81,550.71,259997.5794.2630.3521.5531.2434.7
Net Block 2,317.92,259.92,392.82,2012,019.71,376.81,030.4810.4580.2503.3
Capital Work in Progress759.6126.2346.4237.2234.1273.7155.4174.9236.8105.1
Investments 927.6940.81,034.4702.3776.7716.3158540.4276.6146
Inventories 234332.8179.459.625.243.48632.237.738.4
Sundry Debtors 427.5484.4508.2474.4398.2338.7266.8198.7185.2179.9
Cash and Bank Balance528.2509.3515.1638.2280.3435.4966.5527.3719.9115.7
Loans and Advances 169.6733.4237.1205.5169.3229.1242.3225.5115.3105.8
Total Current Assets1,359.32,059.91,439.81,377.78731,046.61,561.6983.71,058.1439.8
Current Liabilities 914.11,210.1869.4795.3795.1640.2555.2462.5350.8329.4
Provisions 11460.882.259.853.236.826.221.217.49.4
Total Current Liabilities & Provisions1,028.11,270.9951.6855.1848.3677581.4483.7368.2338.8
Net Current Assets331.2789488.2522.624.7369.6980.2500689.9101
Deferred Tax Assets178.3201.6190.3188.5208.3124.6118.497.284.55.1
Deferred Tax Liability128.5122.1125.299.885.633.14633.512.810
Net Deferred Tax49.879.565.188.7122.791.572.463.771.7-4.9
Other Assets419.7381.7282.3270.6135.8197.4210.6201.7132.1227.3
Total Assets4,805.84,577.14,609.24,022.43,313.73,025.32,6072,291.11,987.31,077.8
Contingent Liabilities1,264.21,243.8547.8859.6849.2671.6238.5376.6384.9110.4

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...510
Depreciation425.9
Interest (Net)-15.2
P/L on Sales of Invest-14.4
Prov. and W/O (Net)-14.8
P/L in Forex-3.6
Total Adjustments (PBT and Ext...475.9
Operating Profit before Workin...985.9
Trade and 0ther Receivables86.7
Inventories114.6
Trade Payables-102.7
Total Adjustments (OP before W...181.3
Cash Generated from/(used in) ...1,167.2
Direct Taxes Paid-125.1
Total Adjustments(Cash Generat...-125.1
Cash Flow before Extraordinary...1,042.1
Net Cash from Operating Activi...1,042.1
Purchased of Fixed Assets-510.8
Sale of Fixed Assets22.1
Purchase of Investments-2,804
Sale of Investments2,735.2
Interest Received81.5
Net Cash used in Investing Act...-494.4
Of the Long Tem Borrowings-390.4
Of the Short Term Borrowings-45.2
Of Financial Liabilities-36.8
Dividend Paid-50.3
Interest Paid-28.8
Net Cash used in Financing Act...-551.5
Net Profit before Tax and Extr...466.5
Depreciation368.9
Interest (Net)-31.6
P/L on Sales of Invest-13
Prov. and W/O (Net)-17.8
P/L in Forex-3.3
Total Adjustments (PBT and Ext...380
Operating Profit before Workin...846.5
Trade and 0ther Receivables58.8
Inventories119.1
Trade Payables-116.6
Total Adjustments (OP before W...165.3
Cash Generated from/(used in) ...1,011.8
Direct Taxes Paid-98.4
Total Adjustments(Cash Generat...-98.4
Cash Flow before Extraordinary...913.4
Net Cash from Operating Activi...913.4
Purchased of Fixed Assets-367.2
Sale of Fixed Assets21.6
Purchase of Investments-2,944
Sale of Investments2,516.4
Interest Received81.2
Net Cash used in Investing Act...-382.6
Of the Long Tem Borrowings-390.4
Of the Short Term Borrowings-45.2
Of Financial Liabilities-32.2
Dividend Paid-50.3
Interest Paid-18.2
Net Cash used in Financing Act...-536.3

Company Details

Registered Office
AddressBiocon SEZ Biocon Park,
Plot No 2 & 3 Bommasandra Inds
CityBengaluru
StateKarnataka
Pin Code560099
Tel. No.91-80-68915000/67758781
Fax. No.91-80-28083189
Emailinvestor@syngeneintl.com; Mayank.Verma@syngeneintl
Internethttp://www.syngeneintl.com
Registrars
AddressBiocon SEZ Biocon Park
CityBengaluru
StateKarnataka
Pin Code560099
Tel. No.91-80-68915000/67758781
Fax. No.91-80-28083189
Emailinvestor@syngeneintl.com; Mayank.Verma@syngeneintl
Internethttp://www.syngeneintl.com
Management
Name Designation
Kiran Mazumdar ShawChairperson
Catherine Patricia RosenbergNon Executive Director
Paul Frederick BlackburnIndependent Director
Vijay KuchrooIndependent Director
Jonathan HuntManaging Director & CEO
Vinita BaliLead Independent Director
Priyadarshnini MahapatraCompany Sec. & Compli. Officer
Sharmila KarveIndependent Director
Kush ParmarIndependent Director
SIBAJI BISWASExecutive Director & CFO
Nilanjan RoyIndependent Director
Manja BoermanIndependent Director